Application no. and date | 16862791.7 (espacenet) (Federated) (European Patent Register), 20161101 | Patent/reg. no. and date | DK/EP 3370770, 20210120 | Publication date | 20180912 | Priority no. and date | US 201562250016 P, 20151103 | EP pub. no. and date |
EP 3370770 20180912 | Effective date | | Applicant/owner | Janssen Biotech, Inc., 800/850 Ridgeview Drive
Horsham, PA 19044, US | Applicant ref. no. | P75512DK01 | Inventor | KUMAR, Vineet, 1400 McKean Raod
Spring House, Pennsylvania 19477, US, JANSSON, Richard, 3041 Ursulas Way
Doylestown, Pennsylvania 18902, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/198 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/573 (2006.01) , A61K 31/69 (2006.01) , A61K 39/395 (2006.01) , A61K 47/12 (2006.01) , A61K 47/20 (2006.01) , A61K 47/22 (2006.01) , A61K 9/10 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | SUBKUTANE FORMULERINGER AF ANTI-CD38-ANTISTOFFER OG ANVENDELSER DERAF | Int. application no. | US2016059893 | Int. publication no. | WO2017079150 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|